Takashi Akamizu Selected Research

Hashimoto Disease (Thyroiditis, Hashimoto)

3/2021	Association between serum thyroid hormone balance and thyroid volume in patients treated with levothyroxine monotherapy for hypothyroidism.
3/2012	Functional polymorphisms in TBX21 and HLX are associated with development and prognosis of Graves' disease.
3/2008	The -590CC genotype in the IL4 gene as a strong predictive factor for the development of hypothyroidism in Hashimoto disease.
8/2007	Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: a meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takashi Akamizu Research Topics

Disease

23	Neoplasms (Cancer) 06/2021 - 11/2002
12	Graves Disease (Basedow Disease) 01/2022 - 05/2005
11	Thyroid Diseases (Thyroid Disease) 12/2021 - 09/2003
9	Obesity 11/2019 - 09/2002
9	Body Weight (Weight, Body) 01/2016 - 12/2003
6	Hyperthyroidism 01/2022 - 09/2003
6	Hypothyroidism 01/2022 - 08/2007
6	Cachexia 04/2012 - 04/2004
5	Thyroiditis 01/2022 - 01/2013
5	Immunoglobulin G4-Related Disease 05/2021 - 01/2013
5	Insulin Resistance 05/2020 - 04/2005
5	Dyspepsia (Indigestion) 07/2019 - 06/2005
5	Inflammation (Inflammations) 01/2017 - 12/2008
5	Anorexia 04/2012 - 04/2004
5	Anorexia Nervosa 01/2012 - 07/2003
4	Thyrotoxicosis 10/2021 - 01/2012
4	Diabetes Mellitus 04/2021 - 05/2013
4	Hashimoto Disease (Thyroiditis, Hashimoto) 03/2021 - 08/2007
4	Heart Failure 09/2020 - 05/2007
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2019 - 12/2008
4	Hypoglycemia (Reactive Hypoglycemia) 07/2018 - 09/2002
3	Polyneuropathies (Polyneuropathy) 03/2021 - 11/2011
3	Type 2 Diabetes Mellitus (MODY) 01/2021 - 12/2008
3	Thyroid Crisis (Thyrotoxic Crisis) 09/2020 - 11/2012
3	Pituitary Neoplasms (Pituitary Adenoma) 04/2020 - 01/2017
3	Neuroblastoma 10/2017 - 09/2010
3	Weight Gain 01/2016 - 09/2007
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2014 - 12/2010
3	Chronic Obstructive Pulmonary Disease (COPD) 11/2011 - 05/2007
2	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2021
2	Thyroid Neoplasms (Thyroid Cancer) 10/2021 - 01/2012
2	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 04/2021 - 06/2017
2	Atrophy 03/2021 - 07/2019
2	Pheochromocytoma 06/2020 - 09/2010
2	ACTH-Secreting Pituitary Adenoma 04/2020 - 01/2017
2	Adenoma (Adenomas) 04/2020 - 01/2017
2	Hypertension (High Blood Pressure) 11/2019 - 01/2013
2	Dyslipidemias (Dyslipidemia) 11/2019 - 01/2013
2	Insulinoma 07/2018 - 11/2002
2	Melanoma (Melanoma, Malignant) 07/2018 - 03/2018
2	Hypotension (Low Blood Pressure) 07/2018 - 03/2018
2	Hyponatremia 07/2018 - 03/2018
2	Hyperglycemia 07/2018 - 01/2013
2	Fatigue 07/2018 - 03/2018
2	Chronic Pancreatitis 01/2018 - 09/2017
2	Carcinogenesis 09/2017 - 01/2012
2	Obstructive Sleep Apnea 01/2016 - 08/2015
2	Autoimmune Diseases (Autoimmune Disease) 01/2016 - 01/2011
2	Goiter 01/2012 - 01/2012
1	Papillary Carcinoma 02/2022
1	Papillary Thyroid Cancer 01/2022
1	COVID-19 01/2022

Drug/Important Bio-Agent (IBA)

31	GhrelinIBA 07/2019 - 09/2002
9	Glucose (Dextrose)FDA LinkGeneric 04/2021 - 07/2003
7	AntigensIBA 12/2019 - 09/2003
7	Thyrotropin Receptors (Thyrotropin Receptor)IBA 01/2016 - 09/2003
6	Messenger RNA (mRNA)IBA 01/2022 - 03/2010
6	Immunoglobulin G (IgG)IBA 05/2021 - 01/2013
5	Thyroxine (Levothyroxine)FDA LinkGeneric 02/2022 - 09/2003
5	Insulin (Novolin)FDA Link 04/2021 - 09/2002
5	Immune Checkpoint InhibitorsIBA 05/2020 - 03/2018
5	Hormones (Hormone)IBA 03/2018 - 01/2012
4	Thyroglobulin FDA Link 01/2022 - 09/2003
4	Thyroid HormonesIBA 12/2021 - 08/2007
4	Proteins (Proteins, Gene)FDA Link 06/2020 - 01/2011
4	AntibodiesIBA 07/2018 - 09/2003
4	Adrenocorticotropic Hormone (ACTH)FDA Link 03/2018 - 01/2014
4	Triglycerides (Triacylglycerol)IBA 02/2012 - 04/2005
3	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 02/2022 - 01/2016
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2010
3	RNA (Ribonucleic Acid)IBA 06/2020 - 11/2002
3	Transcription Factors (Transcription Factor)IBA 04/2020 - 06/2012
3	SteroidsIBA 06/2018 - 01/2011
3	DNA (Deoxyribonucleic Acid)IBA 09/2017 - 09/2010
3	Growth Hormone (Somatotropin)IBA 01/2017 - 09/2007
3	Tumor Viral Antigens (Large T Antigen)IBA 07/2012 - 12/2008
3	Pharmaceutical PreparationsIBA 03/2010 - 12/2008
2	Methimazole (Thiamazole)FDA LinkGeneric 01/2022 - 01/2014
2	CreatinineIBA 01/2022 - 01/2014
2	CalciumIBA 03/2021 - 01/2014
2	BilirubinIBA 09/2020 - 01/2018
2	MutS ProteinsIBA 04/2020 - 09/2017
2	NivolumabIBA 07/2018 - 03/2018
2	EnzymesIBA 01/2018 - 09/2017
2	Octreotide (Sandostatin)FDA LinkGeneric 06/2017 - 01/2017
2	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2017 - 01/2017
2	EpitopesIBA 01/2016 - 09/2003
2	CytokinesIBA 01/2016 - 01/2016
2	AutoantigensIBA 01/2016 - 09/2003
2	ChemokinesIBA 01/2016 - 01/2016
2	des-n-octanoyl ghrelinIBA 08/2015 - 04/2005
2	Immunoglobulins (Immunoglobulin)IBA 01/2015 - 04/2014
2	acyl-ghrelinIBA 08/2013 - 02/2012
2	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2013 - 07/2012
2	CC ChemokinesIBA 03/2010 - 12/2008
2	propagermanium (Ge 132)IBA 03/2010 - 12/2008
1	CholesterolIBA 01/2022
1	Oxidoreductases (Dehydrogenase)IBA 01/2022

Therapy/Procedure

18	Therapeutics 01/2022 - 04/2010
3	Thyroidectomy 02/2022 - 10/2021